Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Julien Patris"'
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-8 (2021)
Abstract Background Acute hepatic porphyria (AHP) is a rare, debilitating disease characterized by potentially life-threatening attacks often resulting in chronic symptoms that negatively impact daily functioning and quality of life. Symptoms of AHP
Externí odkaz:
https://doaj.org/article/c4145e5a7061439eb60f1ef7dcd05641
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 14, Iss 1, Pp 1-9 (2019)
Abstract Background A wide range of rare diseases can have fiscal impacts on government finances that extend beyond expected healthcare costs. Conditions preventing people from achieving national lifetime work averages will influence lifetime taxes p
Externí odkaz:
https://doaj.org/article/8884604d64b3467cb5facdca412a1ccd
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-8 (2021)
Orphanet journal of rare diseases, 16(1):346. BMC
Orphanet Journal of Rare Diseases
Orphanet journal of rare diseases, 16(1):346. BMC
Orphanet Journal of Rare Diseases
Background Acute hepatic porphyria (AHP) is a rare, debilitating disease characterized by potentially life-threatening attacks often resulting in chronic symptoms that negatively impact daily functioning and quality of life. Symptoms of AHP prevent m
Autor:
Amanda Whittal, Claudio Jommi, Gérard De Pouvourville, David Taylor, Lieven Annemans, Lies Schoonaert, Sebastian Vermeersch, Adam Hutchings, Julien Patris
Publikováno v:
International journal of technology assessment in health care. 38(1)
Background Acute hepatic porphyria (AHP) is a rare, debilitating disease characterized by potentially life-threatening attacks often resulting in chronic symptoms that negatively impact daily functioning and quality of life. Symptoms of AHP prevent m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d547dae79a07180962961ed8a0f4e33e
https://doi.org/10.21203/rs.3.rs-362734/v1
https://doi.org/10.21203/rs.3.rs-362734/v1
Publikováno v:
Orphanet Journal of Rare Diseases
Orphanet journal of rare diseases, 14(1):220. BMC
Orphanet Journal of Rare Diseases, Vol 14, Iss 1, Pp 1-9 (2019)
Orphanet journal of rare diseases, 14(1):220. BMC
Orphanet Journal of Rare Diseases, Vol 14, Iss 1, Pp 1-9 (2019)
Background A wide range of rare diseases can have fiscal impacts on government finances that extend beyond expected healthcare costs. Conditions preventing people from achieving national lifetime work averages will influence lifetime taxes paid and i
Autor:
Matthias Schwenkglenks, Julien Patris, Patricia R. Blank, Thomas D. Szucs, Christelle Saint Sardos
Publikováno v:
Vaccine. 31:2862-2867
Time from registration to population access to new vaccines can take considerable time in European countries. Reasons might be found in the regulatory framework, decision-making processes or the assessment of vaccines by evaluating bodies. The aim of
Publikováno v:
Orphanet Journal of Rare Diseases
The European Orphan Medicinal Products (OMP) Regulation has successfully encouraged research to develop treatments for rare diseases resulting in the authorisation of new OMPs in Europe. While decisions on OMP designation and marketing authorisation